These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 21688113)
1. Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder. Kurnianingsih YA; Kuswanto CN; McIntyre RS; Qiu A; Ho BC; Sim K J Neural Transm (Vienna); 2011 Nov; 118(11):1621-39. PubMed ID: 21688113 [TBL] [Abstract][Full Text] [Related]
2. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls]. Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195 [TBL] [Abstract][Full Text] [Related]
3. Shared and divergent neurocognitive impairments in adult patients with schizophrenia and bipolar disorder: Whither the evidence? Kuswanto C; Chin R; Sum MY; Sengupta S; Fagiolini A; McIntyre RS; Vieta E; Sim K Neurosci Biobehav Rev; 2016 Feb; 61():66-89. PubMed ID: 26691725 [TBL] [Abstract][Full Text] [Related]
4. Neurocognition in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia. Jiménez-López E; Aparicio AI; Sánchez-Morla EM; Rodriguez-Jimenez R; Vieta E; Santos JL J Affect Disord; 2017 Nov; 222():169-176. PubMed ID: 28709024 [TBL] [Abstract][Full Text] [Related]
5. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862 [TBL] [Abstract][Full Text] [Related]
7. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361 [TBL] [Abstract][Full Text] [Related]
8. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Burdick KE; Funke B; Goldberg JF; Bates JA; Jaeger J; Kucherlapati R; Malhotra AK Bipolar Disord; 2007 Jun; 9(4):370-6. PubMed ID: 17547583 [TBL] [Abstract][Full Text] [Related]
9. The impact of COMT polymorphisms on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders. Pigoni A; Lazzaretti M; Mandolini GM; Delvecchio G; Altamura AC; Soares JC; Brambilla P J Affect Disord; 2019 Jan; 243():545-551. PubMed ID: 30146088 [TBL] [Abstract][Full Text] [Related]
10. Neurocognitive allied phenotypes for schizophrenia and bipolar disorder. Hill SK; Harris MS; Herbener ES; Pavuluri M; Sweeney JA Schizophr Bull; 2008 Jul; 34(4):743-59. PubMed ID: 18448479 [TBL] [Abstract][Full Text] [Related]
11. Assessment of Neurocognitive Functions in 7-Year-Old Children at Familial High Risk for Schizophrenia or Bipolar Disorder: The Danish High Risk and Resilience Study VIA 7. Hemager N; Plessen KJ; Thorup A; Christiani C; Ellersgaard D; Spang KS; Burton BK; Gregersen M; Søndergaard A; Greve AN; Gantriis DL; Poulsen G; Seidman LJ; Mors O; Nordentoft M; Jepsen JRM JAMA Psychiatry; 2018 Aug; 75(8):844-852. PubMed ID: 29926086 [TBL] [Abstract][Full Text] [Related]
12. The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder. Miskowiak KW; Kjaerstad HL; Støttrup MM; Svendsen AM; Demant KM; Hoeffding LK; Werge TM; Burdick KE; Domschke K; Carvalho AF; Vieta E; Vinberg M; Kessing LV; Siebner HR; Macoveanu J Bipolar Disord; 2017 May; 19(3):214-224. PubMed ID: 28544426 [TBL] [Abstract][Full Text] [Related]
13. Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in eastern quebec multigenerational families. Maziade M; Rouleau N; Gingras N; Boutin P; Paradis ME; Jomphe V; Boutin J; Létourneau K; Gilbert E; Lefebvre AA; Doré MC; Marino C; Battaglia M; Mérette C; Roy MA Schizophr Bull; 2009 Sep; 35(5):919-30. PubMed ID: 18550590 [TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorder. Harvey PD; Sun N; Bigdeli TB; Fanous AH; Aslan M; Malhotra AK; Lu Q; Hu Y; Li B; Chen Q; Mane S; Miller P; Rajeevan N; Sayward F; Cheung KH; Li Y; Greenwood TA; Gur RE; Braff DL; ; Brophy M; Pyarajan S; O'Leary TJ; Gleason T; Przygodszki R; Muralidhar S; Gaziano JM; Concato J; Zhao H; Siever LJ Am J Med Genet B Neuropsychiatr Genet; 2020 Apr; 183(3):181-194. PubMed ID: 31872970 [TBL] [Abstract][Full Text] [Related]
15. COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder. Soeiro-de-Souza MG; Machado-Vieira R; Soares Bio D; Do Prado CM; Moreno RA Bipolar Disord; 2012 Aug; 14(5):554-64. PubMed ID: 22713126 [TBL] [Abstract][Full Text] [Related]
16. Neurocognitive Endophenotypes of Schizophrenia and Bipolar Disorder and Possible Associations with FKBP Variant rs3800373. Memic A; Streit F; Hasandedic L; Witt SH; Strohmaier J; Rietschel M; Oruc L Med Arch; 2018 Nov; 72(5):352-356. PubMed ID: 30524168 [TBL] [Abstract][Full Text] [Related]
17. Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls. Wirgenes KV; Djurovic S; Sundet K; Agartz I; Mattingsdal M; Athanasiu L; Melle I; Andreassen OA Schizophr Res; 2010 Sep; 122(1-3):31-7. PubMed ID: 20605701 [TBL] [Abstract][Full Text] [Related]
18. History of psychosis and previous episodes as potential explanatory factors for neurocognitive impairment in first-treatment bipolar I disorder. Demmo C; Lagerberg TV; Aminoff SR; Hellvin T; Kvitland LR; Simonsen C; Andreassen OA; Melle I; Ueland T Bipolar Disord; 2016 Mar; 18(2):136-47. PubMed ID: 26990158 [TBL] [Abstract][Full Text] [Related]
19. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Goldberg TE; Egan MF; Gscheidle T; Coppola R; Weickert T; Kolachana BS; Goldman D; Weinberger DR Arch Gen Psychiatry; 2003 Sep; 60(9):889-96. PubMed ID: 12963670 [TBL] [Abstract][Full Text] [Related]
20. Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia. Burdick KE; Goldberg JF; Harrow M; Faull RN; Malhotra AK J Nerv Ment Dis; 2006 Apr; 194(4):255-60. PubMed ID: 16614546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]